Skip to main content
. 2022 Jan 10;14(2):324. doi: 10.3390/cancers14020324

Figure 2.

Figure 2

Kaplan–Meier Survival Curves for OS and LPFS post-TARE. (A) Overall survival after TARE. (B) Liver progression-free survival after TARE. (C) Overall survival after TARE in patients with DC (disease control) versus PD (progression of disease) at 6 months when assessed by RECIST criteria. (D) Overall survival after TARE in patients with liver PFS equal to or greater than 9 months versus patients with liver PFS lower than 9 months.